Off-road prowess meets family comfort. See how the 2025 Expedition Tremor and Yukon AT4 stack up in power, design, cargo space, and advanced tech. The Ford Expedition Tremor, starting at $81,350, ...

A magnitude 6 earthquake shook Costa Rica on Tuesday, according to the European Mediterranean Seismological Centre. The quake occurred at a depth of 31 km. This image is AI-generated and does not ...

Shares of biopharmaceutical company Praxis Precision Medicines Inc. soared Thursday, boosted by the successful trial of a new drug to treat movement disorders. The drug, ulixacaltamide, targets ...

Ben Stiller couldn’t dodge his kids’ candid thoughts. In his upcoming documentary Stiller & Meara: Nothing Is Lost—which looks back at his childhood and the relationship between his parents Jerry ...

TD Cowen raised Praxis Precision Medicines price target from $61 to $251, maintaining a Buy rating after strong Phase 3 results Ulixacaltamide HCl met primary endpoints in both essential tremor ...

Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations in adults with essential tremor, device maker Fasikl announced. The ...

Praxis Precision Medicines shares more than doubled in premarket trading Thursday after the clinical-stage biopharmaceutical reported positive topline results from a pair of late-stage studies of its ...

Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. After brushing off a recommendation to end a phase 3 study earlier this year based on ...

In March 2023, investors could buy a share of Praxis Precision Medicines for about the same price as a dollar-menu item at a fast food restaurant. The Boston-based biotechnology company had just ...

Findings showed a statistically significant and clinically meaningful improvement in the mADL11 score at week 8 with ulixacaltamide vs placebo. Topline data were announced from two phase 3 trials ...

Kara Alaimo is a professor of communication at Fairleigh Dickinson University. Her book “Over the Influence: Why Social Media Is Toxic for Women and Girls — And How We Can Take It Back” was published ...